Literature DB >> 30409922

Age-related inequalities in colon cancer treatment persist over time: a population-based analysis.

Louise Hayes1, Lynne Forrest2, Jean Adams3, Mira Hidajat4, Yoav Ben-Shlomo4, Martin White3, Linda Sharp1.   

Abstract

BACKGROUND: Older people experience poorer outcomes from colon cancer. We examined if treatment for colon cancer was related to age and if inequalities changed over time.
METHODS: Data from the UK population-based Northern and Yorkshire Cancer Registry on 31 910 incident colon cancers (ICD10 C18) diagnosed between 1999-2010 were obtained. Likelihood of receipt of: (1) cancer-directed surgery, (2) chemotherapy in surgical patients, (3) chemotherapy in non-surgical patients by age, adjusting for sex, area deprivation, cancer stage, comorbidity and period of diagnosis, was examined.
RESULTS: Age-related inequalities in treatment exist after adjustment for confounding factors. Patients aged 60- 69, 70-79 and 80+ years were significantly less likely to receive surgery than those aged <60 years (multivariable ORs (95% CI) 0.84(0.74 to 0.95), 0.54(0.48 to 0.61) and 0.19(0.17 to 0.21), respectively). Age-related differences in receipt of surgery and adjuvant chemotherapy (but not chemotherapy in non-surgical patients) narrowed over time for the 'younger old' (aged <80 years) but did not diminish for the oldest patients.
CONCLUSIONS: Age inequality in treatment of colon cancer remains after adjustment for confounders, suggesting age remains a major factor in treatment decisions. Research is needed to better understand the cancer treatment decision-making process, and how to influence this, for older patients. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer; inequalities; registers

Mesh:

Year:  2018        PMID: 30409922     DOI: 10.1136/jech-2018-210842

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  3 in total

1.  Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients.

Authors:  Xin Chen; Junhao Tu; Xiaolan Xu; Wen Gu; Lei Qin; Haixin Qian; Zhenyu Jia; Chuntao Ma; Yinkai Xu
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

2.  Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050.

Authors:  Sophie Pilleron; Enrique Soto-Perez-de-Celis; Jerome Vignat; Jacques Ferlay; Isabelle Soerjomataram; Freddie Bray; Diana Sarfati
Journal:  Int J Cancer       Date:  2020-08-17       Impact factor: 7.396

3.  A National Study of Colorectal Cancer Survivorship Disparities: A Latent Class Analysis Using SEER (Surveillance, Epidemiology, and End Results) Registries.

Authors:  Francisco A Montiel Ishino; Emmanuel A Odame; Kevin Villalobos; Xiaohui Liu; Bonita Salmeron; Hadii Mamudu; Faustine Williams
Journal:  Front Public Health       Date:  2021-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.